Shanghai Rongtai Health Technology Corp., Ltd. Class A

Shanghai Rongtai Health Technology Corp., Ltd. Class A

SSSE:603579
13.68
CNY
-0.07
(-0.51%)
0.52EPS
32.12P/E
3.58BMarket Cap
Apr 16Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
3.19
5.42
7.51
9.42
10.78
12.61
12.83
11.44
14.88
11.55
10.71
9.23
8.66
8.73
Basic EPS, GAAP
0.2
0.46
1.05
1.52
1.22
1.37
1.64
1.09
1.35
0.95
1.17
1.11
0.83
0.55
Free Cash Flow per Basic Share
0.39
0.58
1.25
0.67
0.69
0.72
1.58
0.48
1.12
0.78
1.47
0.1
0.35
- -
Dividend per Share
0.27
0.13
0.2
0.51
0.28
0.68
0.26
1.17
0.41
0.6
0.45
1.16
0.34
0.5
Book Value per Share
0.98
1.41
2.27
3.31
7.51
8.19
8.95
9.12
9.76
10.26
10.9
11.35
13.7
13.51
Tangible Book Value per Share
0.85
1.18
2.03
3.04
7.12
7.8
8.57
8.75
9.22
9.72
10.31
10.79
13.22
12.73
Basic Weighted Avg Shares
129
133
136
136
178
182
180
177
176
174
173
173
182
200
Sales/Revenue/Turnover
411
723
1,024
1,285
1,918
2,296
2,314
2,021
2,613
2,005
1,855
1,597
1,573
1,746
Operating Margin (%)
5.62
10.14
14.31
16.58
15.68
13.64
12.69
12.05
10.12
8.53
11.63
10.35
6.31
1.44
Depreciation Expense
8
10
13
20
50
90
64
47
63
59
60
57
55
- -
Net Income, GAAP
26
62
143
207
216
249
296
193
236
164
203
192
151
111
Effective Tax Rate (%)
11.38
13.08
13.53
13.82
12.73
11.33
12.09
8.68
12.62
8.17
11.67
8.66
18.67
4.63
Profit Margin (%)
6.28
8.52
13.94
16.08
11.27
10.86
12.77
9.55
9.05
8.19
10.93
12.02
9.58
6.35
Working Capital
49
58
134
222
884
986
925
1,100
1,167
1,380
1,561
1,193
1,469
1,201
LT Debt
4
- -
8
26
- -
30
- -
571
581
603
626
647
- -
- -
Total Equity
131
195
313
457
1,383
1,499
1,631
1,650
1,780
1,870
1,973
2,016
2,788
2,744
Return on Invested Capital (%)
14.33
32.02
50.1
38.21
19.81
15.4
17.18
9.36
9.82
6.39
7.41
6.58
4.95
3.43
Return on Capital (%)
17.1
33.86
52.92
40.41
19.07
16.24
18.53
10.85
11.45
7.1
8.07
6.79
5.56
3.88
Return on Common Equity (%)
19.37
38.42
56.78
54.32
23.78
17.45
18.95
11.74
13.76
9.02
10.57
9.64
6.28
4.65

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
276
435
495
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
201
201
201
Market Capitalization
3,991
3,412
3,579

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
2,316
2,331
2,155
Cash, Cash Equivalents & STI
1,214
1,499
1,433
Accounts Receivable, Net
213
255
152
Inventories
219
212
194
Total Current Liabilities
812
1,039
954
Payables & Accruals
- -
- -
- -
ST Debt
276
435
495
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
32.6%
11.78%
38.34%
Free Cash Flow
40.38%
72.34%
268.75%
Net Income, GAAP
3.72%
-2.29%
-21.49%
Sales/Revenue/Turnover
6.57%
-3.37%
-1.5%
Total Cash Common Dividend
60.46%
8.13%
-69.01%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
401
424
339
433
1,597
2025
395
415
- -
425
1,573
2026
442
549
330
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.37
0.28
0.18
0.28
1.11
2025
0.25
0.24
- -
0.2
0.83
2026
0.35
0.21
-0.21
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.77
- -
0.35
1.16
2025
0.01
0.35
- -
-0.01
0.34
2026
- -
0.5
- -
- -
- -

Company Description

CEO
Qi Lin
Full Time Employees
1,017
Sector
Consumer durables
Industry
Electronics/Appliances
Address
Building 6, Lane 169 Shanghai SH China 201702
IPO Date
Jan 11, 2017
Website
rotai.com
Business
Shanghai Rongtai Health Technology Corporation Limited engages in the design, research and development, production, and sales of health and wellness products, focusing primarily on massage appliances under its Rongtai and Momoda brands. Its product portfolio includes massage chairs and related accessories, neck massagers, eye massagers, massage backrests, massage belts, foot massagers, massage cushions, and hand-held massagers. The company serves both the domestic Chinese market and international customers. Founded in 1997 and headquartered in Shanghai, China, Shanghai Rongtai operates as a leading enterprise in the health technology sector with robust manufacturing and marketing capabilities. Recent strategic initiatives include plans to acquire a 21% stake in its associate company, Shanghai Youmoyouyang Health Technology, which could enhance its market positioning and product development synergy. The company has maintained a focus on innovation, holding over 100 patents related to invention, utility models, and design, and has actively pursued certifications such as ISO9001, ISO13485, and ISO14001 to ensure quality and environmental standards. Although it has faced challenges reflected in a decline in net profit and revenue growth in recent quarters, Shanghai Rongtai continues to invest in expanding its product mix and technology capabilities, aiming to capitalize on growing demand for health and wellness technology. Its ongoing operations emphasize energy-saving materials and environmental responsibility aligned with government and industry standards. Shanghai Rongtai Health Technology Corporation Limited is recognized as a high-tech enterprise in Shanghai and has been awarded multiple honors for its trademarks, innovation, and social contributions. It operates mainly in China but with an international presence through exports and brand promotion. Its core business segment covers wellness and fitness services through advanced massage products designed for both personal consumer use and broader health industry applications. The company is publicly traded on the Shanghai Stock Exchange under ticker 603579.SS.